Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial
Pharmacology, Toxicology and Pharmaceutical Science
2
10%
Agricultural and Biological Sciences
2
10%
Biochemistry, Genetics and Molecular Biology
1
5%
Unknown
8
38%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 December 2016.
All research outputs
#19,103,371
of 27,776,330 outputs
Outputs from Haematologica
#3,924
of 4,987 outputs
Outputs of similar age
#207,809
of 322,726 outputs
Outputs of similar age from Haematologica
#59
of 78 outputs
Altmetric has tracked 27,776,330 research outputs across all sources so far. This one is in the 31st percentile – i.e., 31% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,987 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.7. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 322,726 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
